Discounted Cash Flow (DCF) Analysis Unlevered

KORU Medical Systems, Inc. (KRMD)

$2.1

+0.02 (+0.96%)
All numbers are in Millions, Currency in USD
Stock DCF: - | 2.1 | undervalue

Operating Data

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 17.3523.1624.1823.4927.9031.6535.9040.7346.2052.41
Revenue (%)
EBITDA 3.297.734.04-6.54-10.150.300.340.390.440.50
EBITDA (%)
EBIT 2.987.393.62-7-10.74-0.27-0.31-0.35-0.40-0.45
EBIT (%)
Depreciation 0.310.340.420.460.590.570.650.740.840.95
Depreciation (%)

Balance Sheet Data

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 3.745.8727.3225.3317.4120.8923.7026.8930.5034.60
Total Cash (%)
Account Receivables 1.433.232.574.314.534.274.845.496.237.07
Account Receivables (%)
Inventories 2.102.396.836.116.406.317.158.129.2110.44
Inventories (%)
Accounts Payable 0.450.570.621.232.391.361.541.751.982.25
Accounts Payable (%)
Capital Expenditure -0.48-0.43-1.06-0.38-2.80-1.31-1.48-1.68-1.91-2.16
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 2.1
Beta 0.518
Diluted Shares Outstanding 45
Cost of Debt
Tax Rate 18.87
After-tax Cost of Debt -%
Risk-Free Rate
Market Risk Premium
Cost of Equity 6.730
Total Debt 4.93
Total Equity 94.50
Total Capital 99.43
Debt Weighting 4.95
Equity Weighting 95.05
Wacc

Build Up Free Cash

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 17.3523.1624.1823.4927.9031.6535.9040.7346.2052.41
EBITDA 3.297.734.04-6.54-10.150.300.340.390.440.50
EBIT 2.987.393.62-7-10.74-0.27-0.31-0.35-0.40-0.45
Tax Rate 22.63%18.96%-1.49%28.31%18.87%17.46%17.46%17.46%17.46%17.46%
EBIAT 2.305.993.68-5.02-8.71-0.22-0.25-0.29-0.33-0.37
Depreciation 0.310.340.420.460.590.570.650.740.840.95
Accounts Receivable --1.810.66-1.74-0.220.26-0.57-0.65-0.74-0.84
Inventories --0.28-4.440.72-0.300.10-0.85-0.96-1.09-1.24
Accounts Payable -0.120.050.601.16-1.030.180.210.240.27
Capital Expenditure -0.48-0.43-1.06-0.38-2.80-1.31-1.48-1.68-1.91-2.16
UFCF 2.133.93-0.69-5.34-10.28-1.63-2.32-2.64-2.99-3.39
WACC
PV UFCF -----
SUM PV UFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) -
Free cash flow (t + 1) -3.46
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -12.48
Equity Value -
Shares Outstanding 45
Equity Value Per Share -